close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

49.78 -9.37 (-15.84%)
Official Closing Price Updated: 7:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
46 47 Next >
Trump's Weight-Loss Drug Push May Put These ETFs On A Diet
Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure. 
Via Benzinga
Topics ETFs Government
Why Is Hims & Hers Health Stock Down 12% Today?
According to a SEC filing on Thursday, CEO Andrew Dudum sold 175,661 shares of the company for an aggregate value of about $11 million. 
Via Stocktwits
Topics Regulatory Compliance
Why Hims & Hers Health Shares Are Sliding Friday
Shares of Hims & Hers Health are trading lower Friday morning after comments from President Donald Trump indicated that he expects the prices of popular weight-loss drugs to decrease. 
Via Benzinga
Topics Government
Eli Lilly, Novo Nordisk, Hims & Hers Health Shares Move Lower After Trump Calls Out 'Fat-Loss Drugs'
Shares of Eli Lilly and Novo Nordisk move lower in Thursday's after-hours session after President Trump indicated weight-loss drugs are going to go down in price. 
Via Benzinga
Topics Government
Hims & Hers Health Brings Menopause, Perimenopause Treatments On Its Platform
Via Stocktwits
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.8% in the afternoon session after a Bank of America analyst maintained a Sell rating on the stock, citing multiple concerns about the... 
Via StockStory
Hims & Hers Stock's 150% Surge Is All Fundamentals—No Novo, No Problem
Hims & Hers (HIMS) has seen surprising success, up 150% YTD, driven by their new menopause specialty and refocusing on healthcare. 
Via Benzinga
Hims & Hers Stock Jumps 9% After Huge Announcement
New products are coming to the Hers platform. 
Via The Motley Fool
Hims & Hers Stock Notches Best Day In 3 Months After BofA’s Bullish Call On Menopause Launch: Retail Hails Year’s ‘Best Swing Trade Stock’
The rally followed BofA Securities’ announcement that the new menopause and perimenopause service represents a multi-billion-dollar market opportunity for HIMS, supporting revenue diversification. 
Via Stocktwits
Hims & Hers, Salesforce, Omeros, United Airlines, And Sea Ltd: Why These 5 Stocks Are On Investors' Radars Today
Major U.S. indices ended mixed on Wednesday, with the Dow Jones Industrial Average slipping 0.04% to 46,253.31. 
Via Benzinga
Topics Stocks
Why Hims & Hers Stock Blasted 16% Higher on Wednesday
Investors liked what they heard about the company's latest expansion of its business. 
Via The Motley Fool
Investors Are Buying Hims & Hers Health Stock Following Wednesday's Platform Expansion Announcement
Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Wednesday following the company's launch of a new menopause and perimenopause care specialty on its Hers platform. 
Via Benzinga
Why Are Hims & Hers Health (HIMS) Shares Soaring Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 5.7% in the afternoon session after the company announced the launch of perimenopause and menopause treatment options on its platform.... 
Via StockStory
Topics Artificial Intelligence
IBD 50's Hims & Hers Surges After Announcing A Menopause Care Launch
Shares are nearing a buy point out of a cup-with-handle base. 
Via Investor's Business Daily
Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026
From Hims & Hers
Via Business Wire
Should Investors Buy UnitedHealth Stock Instead of Hims & Hers Stock?
Investors looking at the healthcare industry have two excellent choices with UnitedHealth and Hims & Hers. 
Via The Motley Fool
Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025
From Hims & Hers
Via Business Wire
HIMS & Hers Health Inc (NYSE:HIMS): A High-Growth Telehealth Stock Poised for a Breakout
Discover how Hims & Hers Health (HIMS) combines explosive revenue growth with a bullish technical setup, making it a top telehealth stock to watch. 
Via Chartmill
Why Hims & Hers Health (HIMS) Stock Is Nosediving
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.5% in the afternoon session after a Bank of America report highlighted weakening order trends and a lowered fourth-quarter revenue... 
Via StockStory
Topics World Trade
Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office
From Hims & Hers
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
HIMS & HERS HEALTH INC (NYSE:HIMS) Shows Strong Technical Setup Ahead of Potential Breakout
HIMS stock shows strong technical momentum and a consolidation pattern, suggesting a potential breakout. The setup offers a clear risk/reward profile for technical traders. 
Via Chartmill
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Why Hims & Hers Stock Slipped Today
Investors generally aren't fond of C-suite changes in relatively young businesses. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
HIMS & HERS HEALTH INC (NYSE:HIMS) Shows High-Growth Momentum and Technical Breakout Potential
Hims & Hers (HIMS) is a high-growth momentum stock with strong earnings and a positive technical breakout setup, offering a compelling opportunity for investors. 
Via Chartmill
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. 
Via StockStory
Topics World Trade
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment
 
Via Benzinga
The Secret to Finding the Next Amazon Is Hiding in Plain Sight
These innovators are disrupting massive industries with a customer-centric business strategy. 
Via The Motley Fool
Topics Retirement
Eli Lilly Stock Jumps As Trump’s Drug Price Crackdown Spurs Sector Rally; Analysts Say Pfizer Deal Sets Template For Big Pharma
Via Stocktwits
Topics Government
< Previous 1 2 3 4 5 6 7 8 9
...
46 47 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today